FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,254,000 | -17.1% | 55,956 | -8.3% | 0.02% | -10.5% |
| Q2 2022 | $1,513,000 | -36.6% | 61,051 | -0.7% | 0.02% | -24.0% |
| Q1 2022 | $2,385,000 | -36.5% | 61,508 | -4.2% | 0.02% | -34.2% |
| Q4 2021 | $3,755,000 | -2.2% | 64,181 | -0.9% | 0.04% | 0.0% |
| Q3 2021 | $3,840,000 | -32.7% | 64,781 | -1.4% | 0.04% | -32.1% |
| Q2 2021 | $5,703,000 | +15.4% | 65,716 | +9.6% | 0.06% | +7.7% |
| Q1 2021 | $4,942,000 | -14.1% | 59,938 | -5.2% | 0.05% | -20.0% |
| Q4 2020 | $5,752,000 | +122.9% | 63,252 | -2.1% | 0.06% | +91.2% |
| Q3 2020 | $2,581,000 | -0.5% | 64,580 | -14.6% | 0.03% | -8.1% |
| Q2 2020 | $2,595,000 | – | 75,630 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |